Innovations in Transcatheter Valve Technology: What the Next Five Years Hold.
Document Type
Article
Publication Title
Interventional cardiology clinics
Abstract
Transcatheter aortic valve replacement is indicated for the treatment of symptomatic severe aortic stenosis in patients at intermediate or greater risk for surgery. Future indications may include low-risk patients, asymptomatic patients, bicuspid valves, moderate aortic stenosis, and pure native aortic valve regurgitation. Key hurdles to overcome include pacemaker risk, vascular injury, paravalvular regurgitation, coronary artery reaccess, durability, and embolic risk. New valve designs include synthetic polymeric valves that may allow for greater durability, in addition to advances in terms of precise positioning and repositioning to reduce the complication rate.
First Page
489
Last Page
501
DOI
10.1016/j.iccl.2018.06.004
Publication Date
10-1-2018
Recommended Citation
Sanchez CE, Yakubov SJ, Arshi A. Innovations in Transcatheter Valve Technology: What the Next Five Years Hold. Interv Cardiol Clin. 2018 Oct;7(4):489-501. doi: 10.1016/j.iccl.2018.06.004. Epub 2018 Aug 14. PMID: 30274615.